glp 1 and autoimmune disease Impact of GLP-1 analogues on immune-mediated inflammatory diseases: A systematic review Association between autoimmune diseases and

While neither liraglutide nor semaglutide is FDA-approved for cardiovascular protection, research suggests both may help lower the risk of major heart-related events like heart attack, stroke, or cardiovascular death in people with type 2 diabetes

That's not all GLP-1 does

Los medicamentos GLP-1 disponibles en Estados Unidos incluyen semaglutida inyectable (Ozempic, Wegovy), semaglutida oral (Rybelsus), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda), exenatida (Bydureon BCise) y tirzepatida (Mounjaro, Zepbound)

Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review

Weve seen a couple of studies now that are coming out, especially because of how regularly these medications are being used now, Benjamin Bert, MD, a board-certified ophthalmologist at MemorialCare Orange Coast Medical Center in Fountain Valley, CA who was not involved in any of these studies told Medical News Today